Bank of New York Mellon’s SYMMETRY MEDICAL INC SMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-564,150
Closed -$5.69M 4357
2014
Q3
$5.69M Buy
564,150
+15,629
+3% +$145K ﹤0.01% 2234
2014
Q2
$4.86M Sell
548,521
-16,579
-3% -$145K ﹤0.01% 2334
2014
Q1
$5.68M Buy
565,100
+6,923
+1% +$69K ﹤0.01% 2243
2013
Q4
$5.63M Buy
558,177
+1,900
+0.3% +$16.5K ﹤0.01% 2227
2013
Q3
$4.54M Sell
556,277
-12,234
-2% -$104K ﹤0.01% 2304
2013
Q2
$4.79M Buy
+568,511
New +$5.84M ﹤0.01% 2208

Bank of New York Mellon's SMA Position: Q4 2014 in Review

Bank of New York Mellon sold out of SYMMETRY MEDICAL INC (SMA) in Q4 2014, closing a stake of 564,150 shares — an estimated $5.69M sold.

Bank of New York Mellon first reported a position in SMA in Q2 2013 and held it in 6 quarters. The position peaked at $5.69M in Q3 2014. 0 funds tracked by Wall St. Rank hold SMA as of Q4 2014.

  • Bank of New York Mellon reported no remaining SYMMETRY MEDICAL INC position as of Q4 2014 after selling out during the quarter.
  • Bank of New York Mellon sold 564,150 SYMMETRY MEDICAL INC shares in Q4 2014, an estimated $5.69M.
  • Bank of New York Mellon first reported a position in SYMMETRY MEDICAL INC in Q2 2013 and held it in 6 quarters.
  • Bank of New York Mellon's SYMMETRY MEDICAL INC position peaked at $5.69M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SYMMETRY MEDICAL INC as of Q4 2014.

Based on Bank of New York Mellon's 13F filing for Q4 2014, filed 17 Feb 2015.